Filing Details

Accession Number:
0001225208-10-001397
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-12 12:00:00
Reporting Period:
2010-01-11
Filing Date:
2010-01-12
Accepted Time:
2010-01-12 12:06:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
901219 Human Genome Sciences Inc HGSI In Vitro & In Vivo Diagnostic Substances (2835) 223178468
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346164 Curran Simpson 14200 Shady Grove Road
Rockville MD 20850
Sr. Vp, Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-01-11 326 $30.77 44,570 No 4 S Direct
Common Stock Disposition 2010-01-11 385 $30.91 44,185 No 4 S Direct
Common Stock Disposition 2010-01-11 400 $30.83 43,785 No 4 S Direct
Common Stock Disposition 2010-01-11 628 $30.56 43,157 No 4 S Direct
Common Stock Disposition 2010-01-11 800 $30.89 42,357 No 4 S Direct
Common Stock Disposition 2010-01-11 1,300 $30.77 41,057 No 4 S Direct
Common Stock Disposition 2010-01-11 1,335 $30.56 39,722 No 4 S Direct
Common Stock Disposition 2010-01-11 1,361 $30.82 38,361 No 4 S Direct
Common Stock Disposition 2010-01-11 1,700 $30.53 36,661 No 4 S Direct
Common Stock Disposition 2010-01-11 2,488 $30.54 34,173 No 4 S Direct
Common Stock Disposition 2010-01-11 2,761 $30.80 31,412 No 4 S Direct
Common Stock Disposition 2010-01-11 3,200 $30.68 28,212 No 4 S Direct
Common Stock Disposition 2010-01-11 3,872 $30.56 24,340 No 4 S Direct
Common Stock Disposition 2010-01-11 4,104 $30.71 20,236 No 4 S Direct
Common Stock Disposition 2010-01-11 4,524 $30.58 15,712 No 4 S Direct
Common Stock Disposition 2010-01-11 4,600 $30.85 11,112 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 12/9/09.